From: Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications
Gene-expression signature | Genes | Overlap | Proportion |
---|---|---|---|
SSP2003 [2] | 500 | 5 | 0.010 |
SSP2006 [1] | 306 | 2 | 0.007 |
PAM50 [5] | 50 | 1 | 0.020 |
70 gene poor-prognosis signature [3] | 70 | 0 | 0.000 |
76 gene metastasis signature [4] | 76 | 0 | 0.000 |
Gene-expression grade index [6] | 128 | 1 | 0.008 |
Recurrence score [7] | 21 | 0 | 0.000 |
Recurrence predictor in tamoxifen-treated patients [8] | 181 | 2 | 0.011 |
1677 | 13 | 0.008 |